MUDr. František Folber, Ph.D.
Assistant professor, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 3573, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 63
2024
-
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
Leukemia, year: 2024, volume: 38, edition: 9, DOI
-
Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration
Cancer Medicine, year: 2024, volume: 13, edition: 17, DOI
2023
-
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
Bone Marrow Transplantation, year: 2023, volume: 58, edition: 11, DOI
-
Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry
Frontiers in immunology, year: 2023, volume: 14, edition: March 2023, DOI
-
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use
Annals of hematology, year: 2023, volume: 102, edition: 12, DOI
-
Therapy of adult patients with acute lymphoblastic leukemia based on pediatricinspired protocols in the Czech republic in 2007-2020
Year: 2023, type: Conference abstract
2022
-
Letermovir u pacientů po alogenní transplantaci krvetvorných buněk – přehled literatury
Transfuze a Hematologie Dnes, year: 2022, volume: 28, edition: 1, DOI
-
Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant
British journal of haematology, year: 2022, volume: 196, edition: 3, DOI
-
Single Cycle of Blinatumomab Followed By High-Dose Chemotherapy in the Induction Therapy for Ph-Negative Acute Lymphoblastic Leukemia in Adults. Primary Endpoint Analysis of the Blina-Cell Trial
Year: 2022, type: Conference abstract
-
Very rare near-haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR-T therapy in 19-year-old male patient
CLINICAL CASE REPORTS, year: 2022, volume: 10, edition: 3, DOI